. 2021 Oct 22;21(21):7015. doi: 10.3390/s21217015

Table 2.

Analysis of the two sequences selected as targets for the development of MBs in SARS-CoV-2 variants.

Variant	SARS-CoV-2 Gene	SARS-CoV-2 G4 Sequence	Total of Sequences Analyzed	Number of Sequences with PQS	Conservation (%)
Alpha	ORF1ab	GGTGTTGTTGGAGAAGGTTCCGAAGG	153,813	151,813	99.02
Alpha	S	GGCTTATAGGTTTAATGGTATTGG	153,813	153,259	99.96
Delta	ORF1ab	GGTGTTGTTGGAGAAGGTTCCGAAGG	184,757	180,642	97.77
Delta	S	GGCTTATAGGTTTAATGGTATTGG	184,757	184,691	99.96
Beta	ORF1ab	GGTGTTGTTGGAGAAGGTTCCGAAGG	13,185	12,942	98.16
Beta	S	GGCTTATAGGTTTAATGGTATTGG	13,185	13,175	99.92
Gamma	ORF1ab	GGTGTTGTTGGAGAAGGTTCCGAAGG	36,027	35,930	99.73
Gamma	S	GGCTTATAGGTTTAATGGTATTGG	36,027	36,012	99.96
Lambda	ORF1ab	GGTGTTGTTGGAGAAGGTTCCGAAGG	211	211	100
Lambda	S	GGCTTATAGGTTTAATGGTATTGG	211	211	100
Mu	ORF1ab	GGTGTTGTTGGAGAAGGTTCCGAAGG	3,266	3,247	99.42
Mu	S	GGCTTATAGGTTTAATGGTATTGG	3,266	3,263	99.91